---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-002348"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T13:01:03.598735+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lexaria raises $3.5M in registered direct offering with warrants

## Summary
- Issued 2,661,600 shares at $1.315/share, gross proceeds ~$3.5M.
- Concurrent private placement of warrants for 2,661,600 shares at $1.19 exercise price, 5-year term.
- H.C. Wainwright acted as exclusive placement agent; fees 7% cash plus 93,156 placement agent warrants at $1.6438.
- Net proceeds to fund R&D, working capital, and general corporate purposes.
- Offering closed on December 16, 2025; shares registered under Form S-3, warrants unregistered.

## SEC filing metadata
- accession: 0001640334-25-002348
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033425002348/0001640334-25-002348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033425002348/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-002348
- JSON: https://secwatch.observer/filing/0001640334-25-002348.json
- Plain text: https://secwatch.observer/filing/0001640334-25-002348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.